Cargando…

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

BACKGROUND: Long-term changes in lung cancer (LC) patients are difficult to evaluate. We report results from the French KBP-2020 real-life cohort. METHODS: KBP-2020 was a prospective cohort that included all patients diagnosed with LC in 2020, in nonacademic public hospital in France. Patient and tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debieuvre, Didier, Molinier, Olivier, Falchero, Lionel, Locher, Chrystèle, Templement-Grangerat, Dorine, Meyer, Nicolas, Morel, Hugues, Duval, Yannick, Asselain, Bernard, Letierce, Alexia, Trédaniel, Jean, Auliac, Jean-Bernard, Bylicki, Olivier, Moreau, Lionel, Fore, Mathieu, Corre, Romain, Couraud, Sébastien, Cortot, Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445429/ https://www.ncbi.nlm.nih.gov/pubmed/36108315 http://dx.doi.org/10.1016/j.lanepe.2022.100492

Ejemplares similares

509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
por: Molinier, O., et al.
Publicado: (2022)

Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02–14
por: Auliac, Jean-Bernard, et al.
Publicado: (2019)

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients
por: Gounant, Valérie, et al.
Publicado: (2021)

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)
por: Thureau, Sébastien, et al.
Publicado: (2021)

Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma
por: Bylicki, Olivier, et al.
Publicado: (2020)

Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019
por: Auliac, Jean-Bernard, et al.
Publicado: (2020)

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)
por: Christos, Chouaid, et al.
Publicado: (2012)

First-line management of advanced non-small-cell lung cancer: can we do better?
por: Chouaïd, Christos, et al.
Publicado: (2023)

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis
por: Monnet, Isabelle, et al.
Publicado: (2021)

Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)
por: Vergnenègre, Alain, et al.
Publicado: (2019)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
por: Bylicki, Olivier, et al.
Publicado: (2020)

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge
por: Satgé, Daniel, et al.
Publicado: (2016)

Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study
por: Barlesi, Fabrice, et al.
Publicado: (2020)

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)
por: Corre, Romain, et al.
Publicado: (2018)

Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)
por: Bennouna, Jaafar, et al.
Publicado: (2018)

From gestalt theory to image analysis: a probabilistic approach
por: Desolneux, Agnés, et al.
Publicado: (2008)

Beneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice
por: Gomez-Brouchet, Anne, et al.
Publicado: (2015)

ABO blood groups are not associated with the risk of acquiring SARS-CoV-2 infection in young adults
por: Boudin, Laurys, et al.
Publicado: (2020)

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date
por: Gendarme, Sébastien, et al.
Publicado: (2022)

Heterochromatin protein 1α: a hallmark of cell proliferation relevant to clinical oncology
por: De Koning, Leanne, et al.
Publicado: (2009)

New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab
por: Bylicki, Olivier, et al.
Publicado: (2018)

Pancreaticoduodenectomy with combined superior mesenteric vein resection without reconstruction is possible: A case report and review of the literature
por: Jouffret, Lionel, et al.
Publicado: (2018)

Caseous Necrosis of Mitral Annulus: A Rare Cause of Stroke
por: Corre, Jérôme, et al.
Publicado: (2013)

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)
por: Couraud, S., et al.
Publicado: (2013)

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study
por: Descourt, Renaud, et al.
Publicado: (2022)

Cochlear implantation as a treatment for single-sided deafness and asymmetric hearing loss: a randomized controlled evaluation of cost-utility
por: Marx, Mathieu, et al.
Publicado: (2019)

PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 “EPNEC” study
por: Arpin, Dominique, et al.
Publicado: (2020)

Inspiratory resistances facilitate the diaphragm response to transcranial stimulation in humans
por: Locher, Chrystèle, et al.
Publicado: (2006)

Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey
por: Couraud, Sébastien, et al.
Publicado: (2018)

Impact of Inhibition of the Mitochondrial Pyruvate Carrier on the Tumor Extracellular pH as Measured by CEST-MRI
por: Buyse, Chloé, et al.
Publicado: (2021)

Management and outcomes of non–small cell lung cancer patients with rapid progression under second‐or‐more‐line immune checkpoint inhibitors: ERORECI study (GFPC 2016‐04)
por: Vergnenegre, Alain, et al.
Publicado: (2019)

Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
por: Mahé, Isabelle, et al.
Publicado: (2020)

Modelling Population Dynamics in Realistic Landscapes with Linear Elements: A Mechanistic-Statistical Reaction-Diffusion Approach
por: Roques, Lionel, et al.
Publicado: (2016)

“The 24th Conference” of the Groupement des Pharmacochimistes de l’Arc Atlantique (GP2A)
por: Hélesbeux, Jean-Jacques, et al.
Publicado: (2017)

The Cost of Cochlear Implantation: A Review of Methodological Considerations
por: Nadège, Costa, et al.
Publicado: (2011)

Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care
por: Bylicki, Olivier, et al.
Publicado: (2019)

Genome and Epigenome Surveillance Processes Underlying UV Exposure in Plants
por: Molinier, Jean
Publicado: (2017)

Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population
por: Rossi, Lea, et al.
Publicado: (2015)

Pancreatic Metastasis from Prostate Cancer
por: Jacob, Julian, et al.
Publicado: (2010)

Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small–Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study)
por: Auliac, Jean-Bernard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b3uc1b9jagmfbfplm15thlsrj3